Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 4, 2005, Pages 319-328

  Arafat, T ^a   Awad, R ^a   Hamad, M ^a   Azzam, R ^b   Al Nasan, A ^b   Jehanli, A ^c   Matalka, K ^a  

^a UNIVERSITY OF PETRA   (Jordan)

^b Tabuk Pharmaceutical Mfg Company   (Saudi Arabia)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

EIA; Enalapril; Enalaprilat; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ENALAPRIL; ENALAPRIL MALEATE; ENALAPRILAT; RENETIC; ANTIHYPERTENSIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD PRESSURE; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG MONITORING; ENZYME IMMUNOASSAY; ESTERIFICATION; HUMAN; HYDROLYSIS; MALE; ABSORPTION; ADOLESCENT; CLINICAL TRIAL; FEMALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS;

ABSORPTION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BLOOD PRESSURE; ENALAPRIL; ENALAPRILAT; FEMALE; HUMANS; MALE; THERAPEUTIC EQUIVALENCY;

EID: 26944484487     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00646.x     Document Type: Article

References (18)

1. Patchett AA, Harris E, Tristram EW et al. (1980) A new class of angiotensin-converting enzyme inhibitors. Nature, 288, 280-283.
2. Patchett AA (1984) The chemistry of enalapril. British Journal of Clinical Pharmacology, 18(Suppl. 2), 201S-207S.
3. Greenlee WJ, Allibone PL, Perlow DS et al (1985) Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalapril. Journal of Medicinal Chemistry, 28, 434-442.
4. Todd PA, Heel RC (1986) Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs, 31, 198-248.
5. Tocco DJ, de Luna FA, Duncan AE et al. (1982) The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metabolism and Disposition, 10, 15-19.
6. Ferguson RK, Vlasses PH, Swanson BN et al. (1982) Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clinical Pharmacology and Therapeutics, 32, 48-53.
7. Swanson BN, Stauber KL, Alpaugh WC, Weinstein SH (1985) Radioenzymatic assay of angiotensin converting enzyme inhibitors in plasma and urine. Analytical Biochemistry, 45, 431-436.
8. Hichens M, Hand EL, Mulcahy WS (1981) Radioimmunoassay for angiotensin converting enzyme inhibitors. Ligand Quarterly, 4, 43 (abstract).
9. Alarfaj NA (2003) Flow-injection chemiluminescence determination of enalapril maleate in pharmaceuticals and biological fluids using tri(2′,2′-bipyridyl)ruthenium(II). Analytical Sciences, 19, 1145-1149.
10. Niopas I, Daftsios AC, Nikolaidis N (2003) Bioequivalence study of two brands of enalapril tablets after single oral administration to healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics, 41, 226-230.
11. Najib NM, Idkaidek N, Adel A et al. (2003) Bioequivalence evaluation of two brands of enalapril 20 mg tablets (Narapril and Renitic) in healthy human volunteers. Biopharmaceutics and Drug Disposition, 24, 315-320.
12. Matalka KZ, Arafat T, Hamad M, Jehanli A (2002) Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: Application to pharmacokinetic and pharmacodynamic analysis. Fundamental and Clinical Pharmacology, 16, 23-244.
13. Worland PJ, Jarrott B (1986) Radioimmunoassay for quantitation of lisinopril and enalaprilat. Journal of Pharmaceutical Sciences, 75, 512-516.
14. Greenbaum R, Zucchelli P, Caspi A et al. (2000) Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency. British Journal of Clinical Pharmacology, 49, 23-31.
15. Albarghouthi M, Abu Fara D, Saleem M et al. (2000) Immobilization of antibodies on alginate-chitosan beads. International Journal of Pharmaceutics, 206, 23-34.
16. Matalka K, Arafat T, El-Thaher T et al. (2000) Pharmacokinetic and pharmacodynamic profiles of two brands of amlodipine determined by enzyme linked immunosorbent assay. Pharmacy and Pharmacology Communication, 6, 539-544.
17. Matalka K, El-Thaher T, Saleem M et al. (2001) An enzyme linked immunosorbent assay for determination of amlodipine in plasma. Journal of Clinical Laboratory Analysis, 15, 47-53.
18. Gibaldi M, Perrier M (1982) Pharmacokinetics, 2nd edn. New York: Marcel Dekker.